title: Endometrial thickness and pregnancy outcome after intrauterine insemination.
abstract: OBJECTIVE
  To investigate whether endometrial thickness on the day of hCG administration is a predictor of intrauterine insemination (IUI) success.
  
  
  METHODS
  A retrospective study.
  
  
  METHODS
  Two hundred forty-nine women undergoing IUI cycles.
  
  
  METHODS
  University hospital-based infertility center.
  
  
  METHODS
  Endometrial thickness on the day of hCG administration, cycle parameters, and sperm quality were compared between pregnant and nonpregnant patients. A similar comparison was made between ongoing pregnancies and those that resulted in a loss.
  
  
  METHODS
  Endometrial thickness versus IUI outcome.
  
  
  RESULTS
  The overall pregnancy rate was 15%. Mean (+/- standard deviation) endometrial thickness on the day of hCG administration was significantly greater in cycles where pregnancy was achieved (10.1 +/- 3.0 vs. 7.7 +/- 3.5). In the univariate analysis, the following variables affected the pregnancy rate: the woman's age, duration of infertility, the number of IUI cycles, the number of follicles, the diameter of the dominant follicle, the duration of follicle maturation, and sperm count, motility, and morphology. In the multivariate analysis, the strongest predictor of IUI success was the number of IUI cycles. The woman's age was negatively associated with pregnancy outcome, while endometrial thickness and the total motile sperm count were positively associated with pregnancy outcome.
  
  
  CONCLUSIONS
  The results of the present study suggest that clinicians providing IUI for infertile couples must pay close attention to endometrial development as well as to follicle growth and sperm motility.
authors: Department of Obstetrics and Gynecology, Babol University of Medical Sciences, Mazanderan, Babol, Iran.
authors: Seddigheh
authors: S
authors: Esmailzadeh
authors: Mahbobeh
authors: M
authors: Faramarzi
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D020964:Embryo Loss / Q000175:diagnosis; D004717:Endometrium / Q000033:anatomy & histology*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000628:therapy*; D007315:Insemination, Artificial; D008297:Male; D011247:Pregnancy; D011256:Pregnancy Outcome; D018873:Pregnancy Rate; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D006063:Chorionic Gonadotropin